2157 — Lepu Biopharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$20.21bn
- HK$20.30bn
- CNY934.87m
Annual cashflow statement for Lepu Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -1,029 | -699 | -30.3 | -424 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 198 | 86.4 | -343 | 34.9 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 114 | 36.7 | 19.7 | 92.7 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -622 | -481 | -251 | -196 | — |
| Capital Expenditures | -220 | -115 | -41.2 | -61.7 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 216 | 40.8 | 125 | 0 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.89 | -74.7 | 83.9 | -61.7 | — |
| Financing Cash Flow Items | -11.1 | -56 | -96.3 | -77.1 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 380 | 1,032 | -76.7 | 232 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -248 | 514 | -243 | -24.7 | — |